Viemed Healthcare (VMD) Cash from Financing Activities (2018 - 2026)

Viemed Healthcare's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$6.3 million for Q1 2026.

• Quarterly Cash from Financing Activities fell 271.19% year-over-year to -$6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.4 million (down 156.85% YoY) and the FY2025 annual result came in at -$5.8 million, down 56.93% from the prior year.
• Cash from Financing Activities was -$6.3 million for Q1 2026 at Viemed Healthcare, up from -$8.5 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $11.3 million in Q2 2023 and bottomed at -$8.5 million in Q4 2025.
• A 5-year average of -$1.7 million and a median of -$2.3 million in 2022 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 301.72% — and 2024, when it sank 3535.9%.
• Viemed Healthcare's Cash from Financing Activities stood at -$4.9 million in 2022, then soared by 37.78% to -$3.0 million in 2023, then soared by 113.33% to $404000.0 in 2024, then sank by 2191.83% to -$8.5 million in 2025, then rose by 25.16% to -$6.3 million in 2026.
• Business Quant data shows VMD's Cash from Financing Activities at -$6.3 million in Q1 2026, -$8.5 million in Q4 2025, and $5.0 million in Q3 2025.